Insider Transactions in Q2 2023 at Athenex, Inc. (ATNX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 05
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
8,382
+3.24%
|
$8,382
$1.36 P/Share
|
|
May 05
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
368
+8.16%
|
$368
$1.36 P/Share
|
|
May 05
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,603
+6.74%
|
$3,603
$1.36 P/Share
|
|
Apr 21
2023
|
John Vierling Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,513
+34.57%
|
$6,513
$1.3 P/Share
|
|
Apr 21
2023
|
Jinn Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,513
+15.76%
|
$6,513
$1.3 P/Share
|
|
Apr 21
2023
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+33.37%
|
$2,300
$1.3 P/Share
|
|
Apr 21
2023
|
Benson Kwan Hung Tsang Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,813
+34.25%
|
$8,813
$1.3 P/Share
|
|
Apr 21
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
8,736
+3.48%
|
$8,736
$1.3 P/Share
|
|
Apr 21
2023
|
Manson Fok Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,747
+4.94%
|
$5,747
$1.3 P/Share
|
|
Apr 21
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,755
+7.51%
|
$3,755
$1.3 P/Share
|
|
Apr 21
2023
|
Stephanie A Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,642
+31.24%
|
$3,642
$1.3 P/Share
|
|
Apr 21
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
383
+9.22%
|
$383
$1.3 P/Share
|
|
Apr 07
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
410
+10.79%
|
$410
$1.22 P/Share
|
|
Apr 07
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+3.85%
|
$9,344
$1.22 P/Share
|
|
Apr 07
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+8.64%
|
$4,017
$1.22 P/Share
|